PSI ToxSIG Webinar: Beyond the looking glass - Interpreting animal welfare & behaviour by monitoring & assessing mice activity data
Analysing continuously collected locomotive activity data to interpret mice welfare and behaviour.
Timothy Montague and Ileana Baldi joined us present their work on early phase clinical trials.
Chair: Alun Bedding, Director, GlaxoSmithKline
Speaker: Timothy H Montague, GlaxoSmithKline
Sequential design approaches for bioequivalence studies with crossover designs
Co-authors: Diane Potvin, Charles E. DiLiberti, Walter W. Hauck, Alan F. Parr, Donald J. Schuirmann and Robert A. Smith
Pharmaceutical Statistics, Volume 7, Issue 4, October/December 2008, Pages: 245–262
Plus information from:
Additional results for ‘Sequential design approaches for bioequivalence studies with crossover designs’
(Subsequently published in: Pharmaceutical Statistics, Volume 11, Issue 1, pages 8–13, January/February 2012)
Abstract | Paper+ | Slides
Speaker: Ileana Baldi, Unit of Cancer Epidemiology, CeRMS and CPO Piemonte, University of Turin
Planning a Bayesian early-phase phase I/II study for human vaccines in HER2 carcinomas
Co-authors: Sarah Zohar, Guido Forni, Franco Merletti, Giuseppe Masucci and Dario Gregori
Pharmaceutical Statistics, Volume 10, Issue 3, pages 218–226, May/June 2011
Abstract | Paper+ | Slides